AzTrials
AzTrials

AccommodationNCT06704503

The Changes Under Different Accommodation of Anterior Eye and 3D Crystal Reconstruction.

An observational study of Accommodation, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 2 sites in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Accommodation is defined as a dynamic change in the overall refractive power of the eye during near fixation. Despite extensive investigations, the exact nature of human accommodation remains controversial. Read more about this study

Who is it for?
Ages 20 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Accommodation
How many people
120 participants
Where
2 sitesChina
Study dates
27 Nov 2024to 31 Dec 2028
How long will I take part?
1 Day
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Age 20-80 years old; Astigmatism ≤-1.50D; Best corrected visual acuity ≥4.9;Excluding other systemic underlying diseases; Have a history of eye surgery; Patients with intraocular lens or aphakia; Patients with strabismus and amblyopia; Pregnant or lactating women; People with mental disorders or neurological diseases who cannot cooperate with the examination;

Who may be able to join

  • Patients with astigmatism ≤-1.50D and best corrected visual acuity ≥4.9

Who cannot join

  • Patients with other systemic diseases
  • Patients with a history of eye surgery
  • Patients with intraocular lens or aphakia
  • Patients with strabismus and amblyopia
  • Pregnant or lactating women
  • People with mental disorders or neurological diseases who cannot cooperate with the examination

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

China2 sites, 2 recruiting
  • Second Affiliated Hospital, Zhejiang University School of Medicine

    Hangzhou, Zhejiang, 310009

    Wen Xu, PHD, +86-13858185223, xuwen2003@zju.edu.cn

    Not yet recruiting
  • Second Affiliated Hospital, Zhejiang University School of Medicine

    Hangzhou, Zhejiang, 310009

    wen xu, 13858185223, xuwen2003@zju.edu.cn

    Recruiting

Other trials in China

About this study

Official title: To Study the Changes Under Different Accommodation of Anterior Eye in People of Different Ages and 3D Crystal Reconstruction.

Accommodation is defined as a dynamic change in the overall refractive power of the eye during near fixation. Despite extensive investigations, the exact nature of human accommodation remains controversial. And recent alternative theories question the original concept of accommodation.Different experts have put forward different hypotheses. The age-related changes that underlie presbyopia are also not fully understood.Because of these unanswered questions, the topic of regulation and presbyopia remains a focus of research.

Read the detailed description

Accommodation is the process by which the eye changes the shape and diopter of the lens to obtain a clear image of an object at different distances. Despite extensive research on regulation, the exact nature of human regulation remains controversial. Age-related changes in presbyopia are also not fully understood. Some studies have shown that a hardening of the lens and an increase in the thickness and diameter of the lens with age can lead to presbyopia. Others believe that the main cause is external lens factors, such as age-related changes in the Angle of lens suspension ligament attachment, reduced ciliary body movement, etc. Due to these unanswered questions, the topic of regulation and presbyopia remains the focus of research. In living humans, modulation studies utilize different imaging modes, and ultrasound biomicroscopy (UBM) and Optical Coherence Tomography(OCT) are particularly important in studying anterior segments and modulation. However, UBM is a contact inspection and requires highly skilled technicians. And UBM cannot image the entire anterior segment in a single capture. Anterior segment OCT (AS-OCT), on the other hand, is non-invasive and provides higher resolution imaging, allowing us to capture the morphology of the anterior segment structures in different populations and the changes of the anterior segment structures in response to regulatory stimuli. Studies have shown that with age, reduced anterior chamber depth, pupil contraction, increased lens thickness, increased lens arch height, and loss of posterior ciliary muscle contraction may be biomarkers of early presbyopia. In this study, anterior segment OCT was used to explore whether there were differences in the structural morphology of the anterior segment in people of different ages, and what changes occurred in the structure of the anterior segment after initiation of regulation.

Conditions
Accommodation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06704503
Study groupRoleWhat they receive
Group A was 20-40 years oldThey were divided into three groups according to age: A, B, and C.Group A was 20-40 years old.
Group B was 40-60 years oldThey were divided into three groups according to age: A, B, and C. Group B was 40-60 years old.
Group C was 60-80 years oldThey were divided into three groups according to age: A, B, and C. Group C was 60-80 years old.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Central corneal thickness changes during accommodation

    Central corneal thickness CCT(μm)

    Measured: Baseline, after accommodation(30 minutes after using pilocarpine)

  2. peripheral corneal thickness changes during accommodation

    peripheral corneal thickness(μm)

    Measured: Baseline, after accommodation(30 minutes after using pilocarpine)

  3. anterior chamber depth changes during accommodation

    anterior chamber depth ACD(mm)

    Measured: Baseline, after accommodation(30 minutes after using pilocarpine)

  4. anterior chamber Angle Angle changes during accommodation

    anterior chamber Angle Angle ACA(°)

    Measured: Baseline, after accommodation(30 minutes after using pilocarpine)

  5. anterior opening distance changes during accommodation

    anterior opening distance AOD(mm)

    Measured: Baseline, after accommodation(30 minutes after using pilocarpine)

  6. pupil size changes during accommodation

    pupil size PD(mm)

    Measured: Baseline, after accommodation(30 minutes after using pilocarpine)

  7. lens thickness changes during accommodation

    lens thickness LT(mm)

    Measured: Baseline, after accommodation(30 minutes after using pilocarpine)

  8. anterior and posterior surface curvature radius changes during accommodation

    anterior and posterior surface curvature radius(mm)

    Measured: Baseline, after accommodation(30 minutes after using pilocarpine)

  9. lens arch height changes during accommodation

    lens arch height LV(mm)

    Measured: Baseline, after accommodation(30 minutes after using pilocarpine)

  10. lens sagittal height changes during accommodation

    lens sagittal height(mm)

    Measured: Baseline, after accommodation(30 minutes after using pilocarpine)

  11. anterior chamber volume changes during accommodation

    anterior chamber volume(mm³)

    Measured: Baseline, after accommodation(30 minutes after using pilocarpine)

  12. posterior chamber volume changes during accommodation

    posterior chamber volume(mm³)

    Measured: Baseline, after accommodation(30 minutes after using pilocarpine)

  13. crystal equatorial diameter changes during accommodation

    crystal equatorial diameter(mm)

    Measured: Baseline, after accommodation(30 minutes after using pilocarpine)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Nov 2024
  2. Study start27 Nov 2024
  3. Primary completion31 Dec 2028 (estimated)
  4. Study completion31 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
120 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT06704503
Sponsor's protocol ID
2024-0939
Status last verified
May 2025
First submitted
17 Nov 2024
Last updated
23 May 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Accommodation, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Wen Xu, Phd (+86-13858185223, xuwen2003@zju.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Central corneal thickness changes during accommodation (time frame: Baseline, after accommodation(30 minutes after using pilocarpine)). The study lists 13 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in